TRANSINE
Live / Registered — Registered (as of 16 Aug 2022)
What this means for you
Registered since 16 Aug 2022. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79316838
- Registration number
- 6816931
- Mark type
- Stylized text
- Filed
- 11 Feb 2021
- Published for opposition
- 31 May 2022
- Registered
- 16 Aug 2022
- Attorney of record
- Rebecca Liebowitz
Goods and services
- Class 001 — Chemicals: Chemical preparations for scientific purposes, other than for medical or veterinary use; chemicals for research use, namely, nucleic acid sequences for laboratory or research use; enzymes for research use; DNA and RNA for research use, namely, nucleic acid sequences for laboratory use, nucleic acid sequences for other than medical and veterinary purposes; chemicals for use in the preparation and creation of DNA and RNA, reagents for scientific purposes, other than for medical or veterinary use; enzymes for use in the preparation and creation of DNA and RNA, namely, enzymes for scientific and research purposes; molecular biology research tools in the nature of biological, chemical and biochemical reagents for research use
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; medical and veterinary preparations for therapeutic purposes for the treatment and prevention of ophthalmological conditions, hearing loss, hematologic diseases, immune response disorders, neurological disorders, respiratory diseases, fibrosis, hepatic diseases, renal diseases, diseases of the pancreas, metabolic diseases, genetic conditions, cancer, infectious diseases and cardiovascular diseases; biological, chemical and biochemical reagents, namely, DNA and RNA sequences and gene editing enzymes, all for medical use; DNA and RNA products for medical use, namely, nucleic acid sequences for medical purposes; therapeutic DNA and RNA, namely, nucleic acid sequences for medical purposes
- Class 042 — Scientific and technological services: Scientific and technological services and research and design relating thereto, namely scientific research services in the field of genomics; medical research services including the manipulation of biological reagents to be used for medical or therapeutic purposes; chemical and biological analysis and research services; scientific research into DNA and RNA; research and development into the creation of DNA and RNA; research, development, testing and analysis for scientific research purposes in the field of genomics, DNA and RNA sequencing, gene synthesis, gene identification, gene cloning, gene expression, gene mapping; scientific research in the field of molecular biology, next generation sequencing, high-throughput sequencing and bioinformatics; gene editing services for scientific research purposes; DNA and RNA modelling services, namely genetic mapping for scientific purposes; gene engineering services; research and development services in the creation of genome libraries or collections of biologicals including chemicals and compounds; creating and providing databases or collections of information on normal and mutated genes for scientific research purposes; scientific services relating to the discovery, preclinical and clinical development of therapeutic products, namely therapeutic DNA and RNA; consultancy and advisory services relating to the aforesaid services; research and development of synthetic DNA, RNA, genes and oligonucleotides for others
Owner
Prosecution history
- 21 Mar 2025 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 02 Mar 2024 — CHANGE OF NAME/ADDRESS REC'D FROM IB
- 21 Dec 2022 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 26 Nov 2022 — FINAL DISPOSITION NOTICE SENT TO IB
- 26 Nov 2022 — FINAL DISPOSITION PROCESSED
- 16 Nov 2022 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 26 Oct 2022 — LIMITATION FROM THE IB EXAMINED, NO ACTION IS NEEDED
- 16 Aug 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 16 Aug 2022 — REGISTERED-PRINCIPAL REGISTER
- 20 Jun 2022 — LIMITATION OF GOODS RECEIVED FROM IB
- 31 May 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 31 May 2022 — PUBLISHED FOR OPPOSITION
- 11 May 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 25 Apr 2022 — ASSIGNED TO LIE
- 22 Apr 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER